Altimmune Stock Forecast

Stock Price Forecast

According to 11 analysts polled by S&P Global, Altimmune stock has a consensus rating of "Buy" and an average price target of $15.45. The average 1-year stock price forecast is 396.78% higher than the current stock price, while the lowest is $2.50 (-19.61%) and the highest is $28 (+800.32%).

Price Target: $15.45 (+396.78%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$2.50	$15.45	$15.5	$28
Change	-19.61%	+396.78%	+398.39%	+800.32%

Analyst Ratings

The average analyst rating for Altimmune stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	5	5	6	6	6	7
Buy	3	3	3	3	2	2
Hold	1	1	1	2	2	2
Sell	0	0	0	0	0	0
Strong Sell	1	1	1	0	0	0
Total	10	10	11	11	10	11

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Thomas Smith Leerink Partners	Leerink Partners	Buy Initiates $10	Buy	Initiates	$10	+221.54%	Jun 22, 2026
Patrick Trucchio H.C. Wainwright	H.C. Wainwright	Buy Maintains $20	Buy	Maintains	$20	+543.09%	Jun 4, 2026
Srikripa Devarakonda Truist Financial	Truist Financial	Buy Maintains n/a	Buy	Maintains	n/a	n/a	May 29, 2026
Jonathan Wolleben Citizens JMP	Citizens JMP	Buy Maintains $14 → $11	Buy	Maintains	$14 → $11	+253.70%	May 14, 2026
Eliana Merle Barclays	Barclays	Buy Maintains $20	Buy	Maintains	$20	+543.09%	May 14, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

4.10K

from 41.00K

-90.00%

from 41.00K

Revenue Next Year

n/a

from 4.10K

-100.00%

from 4.10K

EPS This Year

-0.71

from -1.00

EPS Next Year

-0.86

from -0.71

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	4.41M	-68.00K	426.00K	20.00K	41.00K	4.10K
Revenue Growth	-46.12%	-	-	-95.31%	105.00%	-90.00%
Operating Income	-84.84M	-87.65M	-83.51M	-103.17M	-94.49M	-120.80M
Net Income	-97.09M	-84.71M	-88.45M	-95.06M	-88.09M	-111.79M
EPS	-	-	-	-	-1.00	-0.71
Free Cash Flow	-52.56M	-41.69M	-49.98M	-44.87M	-38.72M	-99.20M
No. Analysts	-	-	-	-	-	10

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	41,000
Avg	4,100
Low	n/a

Revenue Growth

Revenue Growth	2026	2027	2028
High	-
Avg	-90.0%
Low	-100.0%

EPS Forecast

EPS	2026	2027	2028
High	-0.52
Avg	-0.71
Low	-0.96

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-